ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
To provide pharmaceutical compositions for treatment of a disorder mediated by complement factor D.SOLUTION: A pharmaceutical composition comprises: a heterocyclic compound represented by the formula in the figure or the like or a pharmaceutically acceptable salt thereof; and a pharmaceutically acce...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HASHIMOTO TERUHIRO AVINASH S PHADKE WANG XIANGZHU WANG QIUPING MILIND DESHPANDE CHEN DAWEI ATUL AGARWAL GODWIN PAIS VENKAT RAO GADHACHANDA JASON ALLAN WILES |
| description | To provide pharmaceutical compositions for treatment of a disorder mediated by complement factor D.SOLUTION: A pharmaceutical composition comprises: a heterocyclic compound represented by the formula in the figure or the like or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.SELECTED DRAWING: Figure 1A
【課題】補体Ｄ因子により媒介される障害の治療のための医薬組成物を提供する。【解決手段】下記式などで表される複素環式化合物又はその薬学的に許容可能な塩と、薬学的に許容可能な担体とを含む医薬組成物による。【選択図】図１Ａ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2021119169A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2021119169A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2021119169A3</originalsourceid><addsrcrecordid>eNrjZPBzDIr00VHwcA1xDfIHsRUc_VygXOdIZx9PZwVnf98A_1A_l2AFN_8ghZAgV8cQX1e_EAV_NwVfVxdPZ0cfBRfPYP8gF9egYB4G1rTEnOJUXijNzaDk5hri7KGbWpAfn1pckJicmpdaEu8VYGRgZGhoaGloZuloTJQiAHoALwM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS</title><source>esp@cenet</source><creator>HASHIMOTO TERUHIRO ; AVINASH S PHADKE ; WANG XIANGZHU ; WANG QIUPING ; MILIND DESHPANDE ; CHEN DAWEI ; ATUL AGARWAL ; GODWIN PAIS ; VENKAT RAO GADHACHANDA ; JASON ALLAN WILES</creator><creatorcontrib>HASHIMOTO TERUHIRO ; AVINASH S PHADKE ; WANG XIANGZHU ; WANG QIUPING ; MILIND DESHPANDE ; CHEN DAWEI ; ATUL AGARWAL ; GODWIN PAIS ; VENKAT RAO GADHACHANDA ; JASON ALLAN WILES</creatorcontrib><description>To provide pharmaceutical compositions for treatment of a disorder mediated by complement factor D.SOLUTION: A pharmaceutical composition comprises: a heterocyclic compound represented by the formula in the figure or the like or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.SELECTED DRAWING: Figure 1A
【課題】補体Ｄ因子により媒介される障害の治療のための医薬組成物を提供する。【解決手段】下記式などで表される複素環式化合物又はその薬学的に許容可能な塩と、薬学的に許容可能な担体とを含む医薬組成物による。【選択図】図１Ａ</description><language>eng ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210812&DB=EPODOC&CC=JP&NR=2021119169A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210812&DB=EPODOC&CC=JP&NR=2021119169A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HASHIMOTO TERUHIRO</creatorcontrib><creatorcontrib>AVINASH S PHADKE</creatorcontrib><creatorcontrib>WANG XIANGZHU</creatorcontrib><creatorcontrib>WANG QIUPING</creatorcontrib><creatorcontrib>MILIND DESHPANDE</creatorcontrib><creatorcontrib>CHEN DAWEI</creatorcontrib><creatorcontrib>ATUL AGARWAL</creatorcontrib><creatorcontrib>GODWIN PAIS</creatorcontrib><creatorcontrib>VENKAT RAO GADHACHANDA</creatorcontrib><creatorcontrib>JASON ALLAN WILES</creatorcontrib><title>ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS</title><description>To provide pharmaceutical compositions for treatment of a disorder mediated by complement factor D.SOLUTION: A pharmaceutical composition comprises: a heterocyclic compound represented by the formula in the figure or the like or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.SELECTED DRAWING: Figure 1A
【課題】補体Ｄ因子により媒介される障害の治療のための医薬組成物を提供する。【解決手段】下記式などで表される複素環式化合物又はその薬学的に許容可能な塩と、薬学的に許容可能な担体とを含む医薬組成物による。【選択図】図１Ａ</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBzDIr00VHwcA1xDfIHsRUc_VygXOdIZx9PZwVnf98A_1A_l2AFN_8ghZAgV8cQX1e_EAV_NwVfVxdPZ0cfBRfPYP8gF9egYB4G1rTEnOJUXijNzaDk5hri7KGbWpAfn1pckJicmpdaEu8VYGRgZGhoaGloZuloTJQiAHoALwM</recordid><startdate>20210812</startdate><enddate>20210812</enddate><creator>HASHIMOTO TERUHIRO</creator><creator>AVINASH S PHADKE</creator><creator>WANG XIANGZHU</creator><creator>WANG QIUPING</creator><creator>MILIND DESHPANDE</creator><creator>CHEN DAWEI</creator><creator>ATUL AGARWAL</creator><creator>GODWIN PAIS</creator><creator>VENKAT RAO GADHACHANDA</creator><creator>JASON ALLAN WILES</creator><scope>EVB</scope></search><sort><creationdate>20210812</creationdate><title>ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS</title><author>HASHIMOTO TERUHIRO ; AVINASH S PHADKE ; WANG XIANGZHU ; WANG QIUPING ; MILIND DESHPANDE ; CHEN DAWEI ; ATUL AGARWAL ; GODWIN PAIS ; VENKAT RAO GADHACHANDA ; JASON ALLAN WILES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2021119169A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HASHIMOTO TERUHIRO</creatorcontrib><creatorcontrib>AVINASH S PHADKE</creatorcontrib><creatorcontrib>WANG XIANGZHU</creatorcontrib><creatorcontrib>WANG QIUPING</creatorcontrib><creatorcontrib>MILIND DESHPANDE</creatorcontrib><creatorcontrib>CHEN DAWEI</creatorcontrib><creatorcontrib>ATUL AGARWAL</creatorcontrib><creatorcontrib>GODWIN PAIS</creatorcontrib><creatorcontrib>VENKAT RAO GADHACHANDA</creatorcontrib><creatorcontrib>JASON ALLAN WILES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HASHIMOTO TERUHIRO</au><au>AVINASH S PHADKE</au><au>WANG XIANGZHU</au><au>WANG QIUPING</au><au>MILIND DESHPANDE</au><au>CHEN DAWEI</au><au>ATUL AGARWAL</au><au>GODWIN PAIS</au><au>VENKAT RAO GADHACHANDA</au><au>JASON ALLAN WILES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS</title><date>2021-08-12</date><risdate>2021</risdate><abstract>To provide pharmaceutical compositions for treatment of a disorder mediated by complement factor D.SOLUTION: A pharmaceutical composition comprises: a heterocyclic compound represented by the formula in the figure or the like or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.SELECTED DRAWING: Figure 1A
【課題】補体Ｄ因子により媒介される障害の治療のための医薬組成物を提供する。【解決手段】下記式などで表される複素環式化合物又はその薬学的に許容可能な塩と、薬学的に許容可能な担体とを含む医薬組成物による。【選択図】図１Ａ</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2021119169A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A18%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HASHIMOTO%20TERUHIRO&rft.date=2021-08-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2021119169A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |